We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $832M Turnover 30.23%
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
-12.97%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$3.1B
AUM Growth
-$987M
Cap. Flow
-$367M
Cap. Flow %
-11.82%
Top 10 Hldgs %
96.1%
Holding
39
New
6
Increased
2
Reduced
3
Closed
6
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.2 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$349M
2
PDD icon
Pinduoduo
PDD
+$264M
3
TSM icon
TSMC
TSM
+$3.32M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.09M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$2.01M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$276M
2
BULL icon
Webull Corp
BULL
+$273M
3
BIDU icon
Baidu
BIDU
+$216M
4
NTES icon
NetEase
NTES
+$120M
5
YMM icon
Full Truck Alliance
YMM
+$52.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 64.88%
2 Healthcare 20.29%
3 Financials 8.67%
4 Technology 3.06%
5 Real Estate 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PDD icon
1
Pinduoduo
PDD
$117B
$1.22B 39.17%
10,721,400
+2,128,800
+25% +$264M
2022 Q2
14 quarters
BABA icon
2
Alibaba
BABA
$276B
$796M 25.65%
5,430,346
+2,140,680
+65% +$349M
2022 Q2
14 quarters
ONC icon
3
BeOne Medicines Ltd
ONC
$42.3B
$314M 10.12%
1,034,306
– –
2018 Q4
28 quarters
FUTU icon
4
Futu Holdings
FUTU
$15.4B
$268M 8.63%
1,630,249
-1,607,930
-50% -$276M
2024 Q2
6 quarters
LEGN icon
5
Legend Biotech
LEGN
$3.85B
$130M 4.19%
5,984,550
– –
2020 Q2
22 quarters
AVBP icon
6
ArriVent BioPharma
AVBP
$828M
$79.1M 2.55%
3,929,117
-555,555
-12% -$11.6M
2024 Q1
7 quarters
BEKE icon
7
KE Holdings
BEKE
$19.6B
$66.8M 2.15%
4,236,278
– –
2020 Q3
21 quarters
BULL icon
8
Webull Corp
BULL
$3.39B
$46.4M 1.5%
5,974,604
-27,106,242
-82% -$273M
2025 Q2
2 quarters
CTKB icon
9
Cytek Biosciences
CTKB
$703M
$33.6M 1.08%
6,657,030
– –
2021 Q3
17 quarters
CWAN icon
10
DELISTED
Clearwater Analytics
CWAN
$32.9M 1.06%
1,365,971
– –
2025 Q2
2 quarters
NBP icon
11
NovaBridge Biosciences American Depositary Shares
NBP
$149M
$23.8M 0.77%
5,980,568
– –
2020 Q3
21 quarters
YSG icon
12
Yatsen Holding
YSG
$249M
$19M 0.61%
4,885,873
– –
2020 Q4
20 quarters
MAZE icon
13
Maze Therapeutics
MAZE
$1.53B
$19M 0.61%
457,535
– –
2025 Q1
3 quarters
GOSS icon
14
Gossamer Bio
GOSS
$54.4M
$15.4M 0.5%
62,176
– –
2019 Q1
27 quarters
API icon
15
Agora
API
$380M
$8.54M 0.28%
2,098,553
– –
2024 Q4
4 quarters
CTNM icon
16
Contineum Therapeutics
CTNM
$297M
$7.65M 0.25%
669,337
– –
2024 Q2
6 quarters
SGMT icon
17
Sagimet Biosciences
SGMT
$579M
$4.29M 0.14%
724,800
– –
2023 Q3
9 quarters
TSM icon
18
TSMC
TSM
$2.19T
$3.43M 0.11%
+11,300
New +$3.32M
2025 Q4
0 quarters
TUYA icon
19
Tuya Inc
TUYA
$1.05B
$3.3M 0.11%
1,564,400
– –
2021 Q1
19 quarters
GE icon
20
GE Aerospace
GE
$324B
$3.09M 0.1%
10,043
– –
2024 Q1
7 quarters
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.27T
$2.28M 0.07%
+7,300
New +$2.09M
2025 Q4
0 quarters
MOGU icon
22
MOGU Inc
MOGU
$15.8M
$1.81M 0.06%
847,510
– –
2019 Q2
26 quarters
IBIT icon
23
iShares Bitcoin Trust
IBIT
$66.2B
$1.75M 0.06%
+35,300
New +$2.01M
2025 Q4
0 quarters
PACB icon
24
Pacific Biosciences
PACB
$609M
$1.72M 0.06%
918,892
– –
2023 Q3
9 quarters
MCO icon
25
Moody's
MCO
$83.8B
$1.48M 0.05%
2,888
– –
2023 Q4
8 quarters

Similar funds

HHLR Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, HHLR Advisors held 39 positions worth $3.1B, down 24% from $4.09B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

HHLR Advisors withdrew a net $367M in Q4 2025, closing 6 positions and reducing 3 holdings. Its most notable exit was Baidu, an estimated $216M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 65% of assets, up from 43% a quarter earlier, followed by Healthcare and Financials.

Against the trend, HHLR Advisors opened a new position in TSMC worth $3.43M.

  • HHLR Advisors's largest Q4 2025 buy was TSMC: 11,300 shares worth $3.43M.
  • HHLR Advisors added most to Alibaba in Q4 2025, an estimated $349M increase.
  • HHLR Advisors's biggest Q4 2025 reduction was Futu Holdings, cutting an estimated $276M.
  • HHLR Advisors fully exited Baidu in Q4 2025, selling an estimated $216M.
  • HHLR Advisors's ten largest holdings make up 96% of its $3.1B portfolio in Q4 2025.
  • HHLR Advisors opened 6 new positions and closed 6 in Q4 2025.
  • HHLR Advisors's portfolio value fell 24% quarter-over-quarter to $3.1B.

Based on HHLR Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.